E Point Perfect
Law \ Legal

Life Sciences Legal Update News; A must-read for all subscribers


After more than 10 years providing updates on a range of topics impacting multinational and global life sciences companies, we’ve made the decision to wind down our Life Sciences Legal Update blog. While the content currently on the blog will still be available to access online in the immediate future, no new content will be posted. Our team has greatly enjoyed using the blog as a vehicle to update subscribers on numerous developing topics, industry trends, and new laws and regulations in this ever-changing industry.

We hope you will join us on by subscribing to our other blogs and platforms, listed below, for future updates.


Please subscribe to Reed Smith’s Health Industry Washington Watch blog for updates regarding legislative and regulatory developments that affect the health care industry.

Please subscribe to the award-winning Drug & Device Law blog for updates and commentary on drug and device product liability developments.


Please subscribe to the Health Care & Life Sciences topic on Passle/Viewpoints for current industry updates.

Thank you for your support over these past 10 years! Happy New Year, and we hope to see you on our other platforms in 2023!


Source link

Related posts

CFPB Advisory Opinion: Pay-to-Pay, “Convenience” Fees Prohibited by FDCPA

Your Social Media Matters… – LexBlog

Import companies in California and New York warned by FDA over violations

Cookies and HIPAA Don’t Always Mix: OCR Issues Guidance on HIPAA and Tracking Technologies

FDA sends warning to seafood firm in Thailand

High Potential Individual Visa – Routes to ILR